( HongKong:2269 )

News from WuXi Biologics A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 08, 2018, 20:04 ET WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jan 30, 2018, 18:52 ET WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jan 29, 2018, 20:00 ET WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jan 24, 2018, 04:05 ET WuXi Biologics Announces Formation of Scientific Advisory Board

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jan 14, 2018, 19:10 ET WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer

WuXi Biologics (WuXi Bio, 02269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for...


Dec 14, 2017, 04:20 ET WuXi Biologics and Phanes Sign MOU and Announce Strategic Development and Manufacturing Partnership

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Dec 06, 2017, 03:23 ET WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors

WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company, offering end-to-end solutions for biologics...


Nov 02, 2017, 22:30 ET WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory

WuXi Biologics (2269.HK), a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Aug 22, 2017, 02:03 ET WuXi Biologics Announces 2017 Interim Results

WuXi Biologics (Cayman) Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global open-access biologics technology platform...


Aug 17, 2017, 07:22 ET WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences

WuXi Biologics (2269.HK), a global leading open-access biologics technology platform company offering end-to-end solutions for biologics discovery,...


Jun 12, 2017, 21:56 ET WuXi Biologics is Officially Listed on the Hong Kong Stock Exchange

On June 13, 2017 Hong Kong time, WuXi Biologics (Cayman) Inc. ("the Company"; stock code: 2269.HK) was officially listed during a grand listing...